AIとがん研究 ── 大腸がん ── 2026-11-19
大腸がん 2 本。筆頭: Noninvasive imaging-based assessment of homologous recombination deficiency for risk stratification and adjuvant chemotherapy guidance in colorectal cancer: a multicenter study
大腸がんの検診・治療・治験とAI
- Noninvasive imaging-based assessment of homologous recombination deficiency for risk stratification and adjuvant chemotherapy guidance in colorectal cancer: a multicenter study抄録(全訳)掲載誌の IF 相当:8.6(OpenAlex の直近 2 年の平均被引用数・2026-11-03 時点の値、2026-11-05 に取得。正式な IF(Clarivate)ではない)書誌:Lei X, Wang R, Li Z, Zhang R, Chen B, Zhou K, et al. Noninvasive imaging-based assessment of homologous recombination deficiency for risk stratification and adjuvant chemotherapy guidance in colorectal cancer: a multicenter study. J Transl Med. 2026 Nov 16 [Epub ahead of print]. doi:10.1186/s12967-026-09237-0.確認の範囲:抄録のみ確認
- AI-driven multi-omics integration and virtual screening identify UFC1 as a druggable effector in chemotherapy-stressed colorectal cancer.抄録(全訳)掲載誌の IF 相当:9.8(OpenAlex の直近 2 年の平均被引用数・2026-11-04 時点の値、2026-11-05 に取得。正式な IF(Clarivate)ではない)